Delivery Order 36F79722D0090-36C26026F0015
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to the Department of Veterans Affairs (VA). The $111,000.00 firm fixed-price delivery order was awarded to Grifols USA LLC, a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is not designated as a set-aside and is issued under the...
- This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024. Grifols USA LLC holds a Federal...
- The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation,...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 20, a civilian agency within the Department of Veterans Affairs (VA). The contract is for the supply of PROLASTIN-C LIQUID, HUMAN 1000MG/VIL, a plasma-derived medicine used to treat alpha1-antitrypsin deficiency. The contract has a ceiling value of $374,760.00 and an ultimate completion date of September 30, 2025. The contract was awarded on October 1, 2024 to Grifols USA LLC, a global...
- This is a federal contract award to Grifols USA LLC, a global healthcare company specializing in plasma-derived medicines and pharmaceutical supplies. The $363,999.71 firm fixed-price delivery order contract was awarded by the Department of Veterans Affairs (VA) for the supply of PROLASTIN-C LIQUID, a human alpha1-proteinase inhibitor medication. The contract is issued under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs and will run through September 30, 2026. This...
- The Department of Veterans Affairs Veterans Health Administration awarded a $109,200 delivery order contract to Grifols USA LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule. The contract calls for Grifols to provide PROLASTIN-C, a drug used to treat alpha-1 antitrypsin deficiency, to facilities located in Los Angeles, California. The base period of performance is one year, from February 8, 2024 through February 7, 2025. Pricing is firm fixed. No subcontractors or...
- This federal contract award is for the delivery of PROLASTIN-C 1000MG VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is a Delivery Order under Grifols' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order contract for PROLASTIN C, a pharmaceutical product, to Grifols Therapeutics LLC, a for-profit limited liability company and manufacturer. The contract was awarded on October 1, 2021 with a potential value of $454,461.44 and a completion date of September 30, 2022. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule, which is a government-wide acquisition...
- The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...